Investigating how a blood factor interacts with platelets during clot formation
Coagulation Factor XII Recruitment and Activation During Thrombus Formation
This study is looking at how a protein called factor XII affects blood clotting and how blocking it might help create new medicines that prevent clots without causing bleeding, which could be really helpful for people with blood clotting problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10914894 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of coagulation factor XII (FXII) in blood clot formation and how it interacts with platelets. The study aims to explore how inhibiting FXII could lead to new antithrombotic medications that prevent blood clots without increasing the risk of bleeding. By using advanced techniques like mass spectrometry, researchers will identify the specific interactions between FXII and platelet receptors, which could pave the way for safer treatments for coagulation disorders. Patients may benefit from insights that could lead to innovative therapies for managing blood clotting issues.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with coagulation disorders or those at risk of thrombosis who are seeking safer treatment options.
Not a fit: Patients who do not have coagulation disorders or are not at risk for thrombosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new medications that effectively prevent blood clots without the risk of bleeding complications.
How similar studies have performed: Previous research has shown promise in targeting coagulation factor XII for antithrombotic therapies, indicating that this approach may be viable.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Bendapudi, Pavan — Beth Israel Deaconess Medical Center
- Study coordinator: Bendapudi, Pavan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.